IKS - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.3
Show all parameters (20 more)
🧾 Trade Setup
Buy at 1765 ₹ with a stop-loss order at 1740 ₹ targeting a profit of 25₹. Alternatively, set an exit level at 1800 ₹ if the stock breaks through this resistance level - otherwise, closely monitor volume; a significant pullback on lower volume could signal a trend reversal and necessitate immediate action to limit losses. Overall, cautiously optimistic given the buying pressure but aware of the premium valuation risk.
✅ Positive
The stock is experiencing a significant surge in volume today – 1.25M shares traded, substantially above the one-week average of 1.45M. Furthermore, DII holding has increased by 1.10% while FII holdings have decreased by -0.18%, suggesting buying pressure from domestic institutional investors.
⚠️ Limitation
Despite strong recent profit growth and impressive returns metrics, the high P/E ratio of 49.2 compared to the industry average of 26.7 indicates a premium valuation that could present a risk if momentum fades or expectations are not fully met. The negative MACD reading suggests potential short-term downward pressure.
📉 Company Negative News
Recent news from Inventurus highlights a projected 48% PAT jump and expanding EBITDA margins to 35%, but this is for FY26, and the scanx.trade report notes a 29% rise over six months – that’s past performance and doesn't guarantee future results.
📈 Company Positive News
The recent news concerning Inventurus includes expansion of EBITDA margins which has driven a 29% increase in the stock price over the last 6 months, signalling positive investor sentiment.
🏭 Industry
The Healthcare Tech sector is currently experiencing increased investment due to digitalization trends and rising demand for digital health solutions, however, high valuations remain prevalent within this industry and create pressure on margin expansion companies.